Related Experiment Video
Updated: Dec 27, 2025

07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
9.3K
The solid progress of nanomedicine
João Pedro Martins1, José das Neves2, María de la Fuente3
1Drug Research Program, Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.
Drug Delivery and Translational Research
|March 7, 2020
Abstract:
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.

